Donald Jones

Donald Jones is a globally recognized leader in digital medicine, digital therapies, technology enabled health services and virtual clinic business models. He works across a spectrum of healthcare, pharmaceutical, medical device, wearable, smart apparel, material science and healthcare AI companies. He is an Operating Partner with Takeda Digital Ventures. As Chair of the Cardiff Ocean Group, he is an independent director on the boards of venture capital and private equity backed companies with investors including Searchlight Capital, L'Catterton Partners, Flex, Samsung, Omron, GE and Takeda. His Fortune 1000 Advisory Boards have included Flex, TEVA, JSR, Sanofi, Otsuka, Takeda, Astra Zeneca, Cepheid and MAS Holdings. Don has advised the Boards and executive suites of many of the largest pharmaceutical companies. He has the Verily/Sanofi joint venture, Onduo and advises Huami/PAI, the world’s largest wearables company. He is a Senior Advisor with both McKinsey & Company and the GLG Institute. Jones serves as Chief Digital Officer (Emeritus) of the Scripps Research Translational Institute (SRTI), an Institute within Scripps Research, collaborating with the renowned Eric Topol, MD. He co-founded Scripps Digital Medicine, the world’s first digital health clinical trial center and the non-profit West Health Institute, raising over $130 million.